ES245760A1 - Procedure for the preparation of heterocyclic derivatives of morphates (Machine-translation by Google Translate, not legally binding)
- Google Patents
Procedure for the preparation of heterocyclic derivatives of morphates (Machine-translation by Google Translate, not legally binding)
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AGfiledCriticalF Hoffmann La Roche AG
Priority to ES0245760ApriorityCriticalpatent/ES245760A1/en
Publication of ES245760A1publicationCriticalpatent/ES245760A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Process for the preparation of heterocyclic morphinan derivatives of the general formula wherein r is a 5 or 6 membered unsaturated heterocyclic ring which may be substituted by alkyl radicals And its acid addition salts comprising substituting the N-atom hydrogen atom of a 3-hydroxy-morphinan for a radical -ch2 -ch2 -r in the one that r has the same meaning indicated before. (Machine-translation by Google Translate, not legally binding)
ES0245760A1958-12-031958-12-03Procedure for the preparation of heterocyclic derivatives of morphates (Machine-translation by Google Translate, not legally binding)
ExpiredES245760A1
(en)
Procedure for obtaining new derivatives of piperidil-2 phenylmethanols and their added salts (Machine-translation by Google Translate, not legally binding)
Procedure for obtaining a derivative of 1,1-dioxide from 3,4-hydride-1,2,4-benzotiadiacin (Machine-translation by Google Translate, not legally binding)